Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Gland Pharma Ltd.

Price on BSE   24 Apr,15:29 LIVE
1,718.80
-79.20
(-4.40%)

© 2026 Rediff.com
  • Volume :
  • 5,566.00
  • Prev Close :
  • 1,798.00
  • Day's H/L (Rs.) :
  • 1,793.50 - 1,705.10
  • 52wk H/L (Rs.) :
  • 2,130.00 - 1,382.10
  • Mkt Cap (Rs. Cr) :
  • 28,325.83
Price on NSE   24 Apr,15:59 LIVE
1,713.50
-81.90
(-4.56%)

© 2026 Rediff.com
  • Volume :
  • 161,904.00
  • Prev Close :
  • 1,795.40
  • Day's H/L (Rs.) :
  • 1,798.10 - 1,702.90
  • 52wk H/L (Rs.) :
  • 2,131.00 - 1,382.30
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Gland Pharma Ltd.
PE Ratios
25.99
EPS (Rs.)
66.14
Sales (Rs. Cr)
1,177.51
Face Value (Rs.)
1
Net Profit Margin(%)
26.47
Last Bonus
-
Last Dividend(%)
1800
Return on Average Equity
11.17

News for Gland Pharma Ltd.

Biopharma Investment Boosts Anthem, Biocon Stocks
Budget 2024 proposes Rs 10,000 crore investment in biopharma. Anthem Biosciences, Biocon stocks jump. Impact on pharma sector.
Feb 01, 2026 11:51
Gland Pharma Q2 PAT Up 12% to Rs 184 Cr
Gland Pharma reports Q2 PAT of Rs 184 cr, a 12% YoY increase, driven by Cenexi. Revenue rises to Rs 1,487 cr. USA up 10%, Europe 16%.
Nov 03, 2025 18:55
Gland Pharma's USFDA Nod for Generic Drug
Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection, gaining 180-day exclusivity. The generic drug treats low blood pressure.
Jun 04, 2025 16:16
Gland Pharma Gets USFDA Nod for Generic Eye Pressure Drug
Gland Pharma receives USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, a bioequivalent to Bausch and Lomb's Vyzulta, for treating high eye pressure.
Apr 30, 2025 18:55
Pharma Stocks Sink Amid US Tariff Threat
Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...
Apr 09, 2025 17:55

More News for Gland Pharma Ltd. »

News for Pharmaceuticals and health care

JioMart: Reliance Retail Expands Hyperlocal Network
Reliance Retail''s JioMart expands to 1200 cities via 3100 stores. Two-hour delivery now available for electronics & fashion.
Apr 24, 2026 22:29
ATSEPA Concerns: Air Traffic Control Privatisation
ATSEPA raises concerns over proposed privatisation of air traffic control services. Warns of weakened national capabilities.
Apr 24, 2026 22:23
Panel to Assess Mythos Risks: SBI Chief Setty Leads
Govt forms panel under SBI chief Setty to assess risks from AI platform Mythos. Banks to review defenses against potential cyber attacks.
Apr 24, 2026 22:21
Reliance Consumer Products Revenue: Rs 7,350 Cr
Reliance Consumer Products Ltd (RCPL) reports Rs 7,350 cr revenue in March quarter, a 2.2x YoY increase. FY26 revenue crossed Rs 22,000 crore.
Apr 24, 2026 22:17
JioStar Revenue & Viewership Soar in FY26, IPL 2026
JioStar reports Rs 36,248 cr revenue in FY26, crossing 515 million viewers during IPL 2026. Digital ad revenue hits record high.
Apr 24, 2026 21:38

More News »

Top News

JioMart: Reliance Retail Expands Hyperlocal Network
Reliance Retail''s JioMart expands to 1200 cities via 3100 stores. Two-hour delivery now available for electronics & fashion.
Apr 24, 2026 22:29
ATSEPA Concerns: Air Traffic Control Privatisation
ATSEPA raises concerns over proposed privatisation of air traffic control services. Warns of weakened national capabilities.
Apr 24, 2026 22:23
Panel to Assess Mythos Risks: SBI Chief Setty Leads
Govt forms panel under SBI chief Setty to assess risks from AI platform Mythos. Banks to review defenses against potential cyber attacks.
Apr 24, 2026 22:21
Reliance Consumer Products Revenue: Rs 7,350 Cr
Reliance Consumer Products Ltd (RCPL) reports Rs 7,350 cr revenue in March quarter, a 2.2x YoY increase. FY26 revenue crossed Rs 22,000 crore.
Apr 24, 2026 22:17
Indusind Bank Q4 Profit: Loan Growth Target FY27
Indusind Bank reports Rs 594 cr profit for Q4. Aims for industry-level loan growth in FY27. Focus on AI and strategic priorities.
Apr 24, 2026 21:55

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com